China SXT Pharmaceuticals (SXTC) Receivables (2018 - 2026)
China SXT Pharmaceuticals (SXTC) posted quarterly Receivables of $16.8 million for Q1 2026, up 876.04% year-over-year from $1.7 million in Q1 2025, and up 256.02% quarter-over-quarter from $4.7 million in Q3 2025.
China SXT Pharmaceuticals (SXTC) Receivables (2018 - 2026) Analysis & Trends
China SXT Pharmaceuticals' Receivables history runs 9 years deep, the most recent figure standing at $16.8 million for Q1 2026.
- In Q1 2026, Receivables rose 876.04% year-over-year to $16.8 million; the TTM figure through Mar 2026 stood at $16.8 million (up 876.04% YoY), while the FY2026 annual figure was $18.7 million, up 392.4% from the prior year.
- Receivables for Q1 2026 stood at $16.8 million, up from $4.7 million in the prior quarter.
- The five-year high for Receivables was $16.8 million in Q1 2026, with the low at $1.7 million in Q1 2025.
- The 5-year median for Receivables is $4.5 million (2024), against an average of $5.4 million.
- The sharpest annual moves came in 2022 and 2023: Receivables jumped 2412.83% in 2022, then sank 58.97% in 2023.
- China SXT Pharmaceuticals' Receivables stood at $6.8 million in 2022, then tumbled by 58.97% to $2.8 million in 2023, then jumped by 64.19% to $4.5 million in 2024, then grew by 3.61% to $4.7 million in 2025, then surged by 256.02% to $16.8 million in 2026.
- Business Quant data shows SXTC's Receivables at $16.8 million in Q1 2026, $4.7 million in Q3 2025, and $1.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 3.07 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 3.49 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 1.57 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 5.84 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 310.30 Mn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 3.67 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 887.00 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.15 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 1.08 Bn |
| 10 | China SXT Pharmaceuticals | 32,922.00 | -28.14 Mn | - | 18.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16.78 Mn |
| Sep 30, 2025 | 4.71 Mn |
| Mar 31, 2025 | 1.72 Mn |
| Sep 30, 2024 | 4.55 Mn |
| Mar 31, 2024 | 3.13 Mn |
| Sep 30, 2023 | 2.77 Mn |
| Mar 31, 2023 | 3.10 Mn |
| Sep 30, 2022 | 6.75 Mn |
| Mar 31, 2022 | 4.67 Mn |
| Sep 30, 2021 | 268,677.00 |
| Mar 31, 2021 | 4.96 Mn |
| Sep 30, 2020 | 6.15 Mn |
| Mar 31, 2020 | 5.39 Mn |
| Sep 30, 2019 | 8.13 Mn |
| Mar 31, 2019 | 9.92 Mn |
| Sep 30, 2018 | 3.89 Mn |
| Mar 31, 2018 | 2.74 Mn |